Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| nef Gene Products, Human Immunodeficiency Virus | 11 | 2017 | 53 | 1.360 |
Why?
|
| Exosomes | 6 | 2017 | 124 | 0.890 |
Why?
|
| Peptides | 5 | 2024 | 357 | 0.860 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 62 | 0.790 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 65 | 0.780 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1679 | 0.580 |
Why?
|
| Apoptosis | 7 | 2019 | 1541 | 0.530 |
Why?
|
| Clusterin | 1 | 2017 | 9 | 0.530 |
Why?
|
| HIV-1 | 11 | 2016 | 747 | 0.450 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 225 | 0.410 |
Why?
|
| Gene Products, nef | 4 | 2005 | 19 | 0.350 |
Why?
|
| HIV Infections | 5 | 2016 | 2535 | 0.340 |
Why?
|
| Receptors, CXCR4 | 3 | 2008 | 74 | 0.330 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 979 | 0.290 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 378 | 0.230 |
Why?
|
| Cell Proliferation | 3 | 2022 | 1420 | 0.220 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 2598 | 0.210 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 68 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 232 | 0.200 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 91 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2015 | 301 | 0.190 |
Why?
|
| Vimentin | 1 | 2022 | 38 | 0.190 |
Why?
|
| Humans | 18 | 2024 | 42163 | 0.180 |
Why?
|
| Biofilms | 1 | 2024 | 178 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 415 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Virion | 3 | 2016 | 73 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 34 | 0.150 |
Why?
|
| Cell Movement | 1 | 2022 | 640 | 0.150 |
Why?
|
| Cell Line | 6 | 2019 | 1416 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 101 | 0.130 |
Why?
|
| Transfection | 5 | 2013 | 526 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 426 | 0.120 |
Why?
|
| Female | 4 | 2022 | 24018 | 0.120 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2013 | 52 | 0.120 |
Why?
|
| China | 1 | 2015 | 233 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 1188 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2017 | 884 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1559 | 0.110 |
Why?
|
| AIDS Dementia Complex | 1 | 2015 | 116 | 0.110 |
Why?
|
| Cytokines | 2 | 2016 | 661 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2015 | 317 | 0.110 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 94 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 51 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2011 | 36 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 515 | 0.090 |
Why?
|
| Jurkat Cells | 3 | 2008 | 84 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2019 | 2111 | 0.090 |
Why?
|
| Prevalence | 1 | 2015 | 1597 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.090 |
Why?
|
| Transport Vesicles | 1 | 2010 | 22 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2015 | 501 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2016 | 1617 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2803 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 875 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2008 | 126 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 138 | 0.070 |
Why?
|
| Neuroglia | 1 | 2008 | 131 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 200 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 74 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 146 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 261 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2008 | 411 | 0.060 |
Why?
|
| Aged | 2 | 2015 | 7982 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 4936 | 0.060 |
Why?
|
| United States | 1 | 2015 | 5072 | 0.060 |
Why?
|
| Male | 3 | 2015 | 22779 | 0.060 |
Why?
|
| Adolescent | 1 | 2015 | 5950 | 0.050 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2004 | 8 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2004 | 36 | 0.050 |
Why?
|
| Middle Aged | 2 | 2015 | 11819 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2004 | 67 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 96 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 246 | 0.050 |
Why?
|
| Adult | 2 | 2015 | 13458 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1804 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2012 | 52 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 456 | 0.040 |
Why?
|
| Animals | 4 | 2019 | 16695 | 0.040 |
Why?
|
| Brain | 1 | 2008 | 1452 | 0.040 |
Why?
|
| Protein Transport | 2 | 2011 | 295 | 0.040 |
Why?
|
| Mice | 2 | 2008 | 6490 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 502 | 0.040 |
Why?
|
| Protein Binding | 2 | 2013 | 1076 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 14 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 122 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 310 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 344 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 534 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 188 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 85 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 185 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 491 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 273 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 150 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3701 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 226 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 427 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 475 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 183 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 670 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1729 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1066 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 26 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 207 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 293 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1058 | 0.020 |
Why?
|
| Neurons | 1 | 2015 | 1246 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 181 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 167 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 318 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 324 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 38 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 98 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 1169 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 158 | 0.010 |
Why?
|
| HIV-2 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Cyclophilin A | 1 | 2004 | 19 | 0.010 |
Why?
|
| Hela Cells | 1 | 2004 | 370 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 276 | 0.010 |
Why?
|